Development and validation of a high performance chromatographic method for determining sumatriptan in niosomes

Journal of Pharmaceutical and Biomedical Analysis

Volumn 72, Issue , 2013, Pages 251-260

  Cozar Bernal M J ^a   Rabasco, A M ^a   Gonzalez Rodriguez M L ^a  

^a UNIVERSITY OF SEVILLE   (Spain)

Author keywords

Factorial design; Method validation; Reversed phase HPLC (RP HPLC); Robustness; Sumatriptan succinate; Taguchi

Indexed keywords

ACETONITRILE; NIOSOME; PHOSPHATE; SUMATRIPTAN SUCCINATE;

ANALYTIC METHOD; ARTICLE; DRUG DETERMINATION; ENCAPSULATION; FLOW RATE; PH; PRIORITY JOURNAL; QUALITY CONTROL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SIGNAL NOISE RATIO; VALIDATION PROCESS;

CHEMISTRY, PHARMACEUTICAL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHROMATOGRAPHY, REVERSE-PHASE; LIPOSOMES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SIGNAL-TO-NOISE RATIO; SUMATRIPTAN;

EID: 84869088088     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.08.030     Document Type: Article

References (32)

1. Rang H.P., Dale M.M., Ritter J.M., Flower R.J. Rang and Dale's Pharmacology 2008, Elsevier, Madrid. sixth ed.
2. Balaguer-Fernández C., Femenía-Font A., Merino V., Córdoba-Díaz D., Elorza-Barroeta M.A., López-Castellano A., Córdoba-Díaz M. Elastic vesicles of sumatriptan succinate for transdermal administration: characterization and in vitro studies. J. Liposome Res. 2011, 21:55-59.
3. Balakrishnan P., Shanmugam S., Lee W.S., Lee W.M., Kim J.O., Oh D.H., Kim D.D., Kim J.S., Yoo B.K., Choi H.G., Woo J.S., Yong C.S. Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery. Int. J. Pharm. 2009, 377:1-8.
4. Muzzalupo R., Tavano L., Cassano R., Trombino S., Ferrarelli T., Picci N. A new approach for the evaluation of niosomes as effective transdermal drug delivery systems. Eur. J. Pharm. Biopharm. 2011, 79:28-35.
5. González-Rodríguez M.L., Rabasco A.M. Charged liposomes as carriers to enhance the permeation through the skin. Expert Opin. Drug Deliv. 2011, 8:1-15.
6. Manconi M., Sinico C., Valenti D., Lai F., Fadda A.M. Niosomes as carriers for tretinoin: III. A study into the in vitro cutaneous delivery of vesicle-incorporated tretinoin. Int J. Pharm. 2006, 311:11-19.
7. Andrew P.D., Birch H.L., Phillpot D.A. Determination of sumatriptan succinate in plasma and urine by high-performance liquid chromatography with electrochemical detection. J. Pharm. Sci. 1993, 82:73-76.
8. Ravi S., Darwis Y., Khan N. Development and validation of an RP-HPLC-UV method for analysis of sumatriptan succinate in pharmaceutical dosage forms. Acta Chromatogr. 2009, 21:421-432.
9. Singh L., Nanda S., Chomwal R. A validated sensitive chromatographic method for the estimation of sumatriptan succinate in bulk drug and tablet dosage form. Chron. Young Sci. 2011, 2:37-41.
10. Jahanshahi M., Sanati M.H., Babaei Z. Optimization of parameters for fabrication of gelatin nanoparticles by the Taguchi robust design method. J. Appl. Stat. 2008, 35:1345-1353.
11. López-Cacho J.M., González-R P.L., Talero B., Rabasco A.M., González-Rodríguez M.L. Robust optimization of alginate-carbopol 940 bead formulations. TSWJ 2012, 2012:1-15. 10.1100/2012/605610.
12. Taguchi G., Phadke M.S. GLOBECOM 84 Meeting IEEE Communication Society November 1984, 1106.
13. Rao R.S., Kumar C.G., Prakasham R.S., Hobbs P.J. The Taguchi methodology as a statistical tool for biotechnological applications: a critical appraisal. Biotechnol. J. 2008, 3:510-523.
14. Torrealday N., González L., Alonso R.M., Jiménez R.M., Ortiz Lastra E. Experimental design approach for the optimisation of a HPLC-fluorimetric method for the quantitation of the angiotensin II receptor antagonist telmisartan in urine. J. Pharmaceut. Biomed. 2003, 32:847-857.
15. das Nevesa J., Sarmento B., Amijic M.M., Bahia M.F. Development and validation of a rapid reversed-phase HPLC method for the determination of the non-nucleoside reverse transcriptase inhibitor dapivirine from polymeric nanoparticles. J. Pharm. Biomed. Anal. 2010, 52:167-172.
16. Ferrarini A., Huidobroa A.L., Pellati F., Barbas C. Development and validation of a HPLC method for the determination of sertraline and three non-chiral related impurities. J. Pharm. Biomed. Anal. 2010, 53:122-129.
17. Villasmil S., Dhrimeur W., Salas S., Rabasco A.M., González-Rodríguez M.L. Positively and negatively charged liposomes as carriers for transdermal delivery of sumatriptan: in vitro characterization. Drug Dev. Ind. Pharm. 2010, 36:666-675.
18. Kriera F., Briona M., Debrusb B., Lebrunb P., Driesena A., Ziemonsb E., Evrarda B., Hubertb P. Optimisation and validation of a fast HPLC method for the quantification of sulindac and its related impurities. J. Pharm. Biomed. Anal. 2011, 54:694-700.
19. Taguchi G. Introduction to Quality Engineering, Quality Resources 1986, Asian Productivity Organization, New York.
20. Mousavi S.M., Yaghmaei S., Jafari A., Vossoughi M. Optimization of ferrous biooxidation rate in a packed bed bioreactor using Taguchi approach. Chem. Eng. Process. 2007, 46:935-940.
21. Madu I.E., Madu C.N. Design optimization using signal-to-noise ratio. Simul. Pract. Theory 1999, 7:349-372.
22. Khosla A., Kumar S., Aggarwal K.K. Identification of strategy parameters for particle swarm optimizer through Taguchi method. J. Zhejiang Univ. Sci. A 2006, 7:1989-1994.
23. Tan O., Sahin A., Hinislioglu S., Altun S. Taguchi approach for optimization of the bleeding on cement-based grouts. Tunn. Undergr. Space Technol. 2005, 20:167-173.
24. Sahin Y. Optimal testing parameters on the wear behaviour of various steels. Mater. Design 2006, 27:455-460.
25. Belfast M., Lu R., Capen R., Zhong J., Nguyen M.A., Giménez J., Sitrin R., Mancinelli R. A practical approach to optimization and validation of a HPLC assay for analysis of polyribosyl-ribitol phosphate in complex combination vaccines. J. Chromatogr. B 2006, 832:208-215.
26. Srinubabu G., Raju C.A.I., Sarath N., Kiran Kumar P., Seshagiri Rao J.V.L.N. Development and validation of a HPLC method for the determination of voriconazole in pharmaceutical formulation using an experimental design. Talanta 2007, 71:1424-1429.
27. Kriera F., Brion M., Debrus B., Lebrun P., Driesen A., Ziemons E., Evrard B., Hubert P. Optimisation and validation of a fast HPLC method for the quantification of sulindac and its related impurities. J. Pharm. Biomed. Anal. 2011, 54:694-700.
28. Ficarra R., Ficarra P., Tommasini S., Melardi S., Calabrò M.L., Furlanetto S., Semreen M. Validation of a LC method for the analysis of zafirlukast in a pharmaceutical formulation. J. Pharm. Biomed. Anal. 2000, 23:169-174.
29. Ficarra R., Calabrò M.L., Cutroneo P., Tommasini S., Melardi S., Semreen M., Furlanetto S., Ficarra P., Altavilla G. Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental design. J. Pharm. Biomed. Anal. 2002, 29:1097-1103.
30. Xie S., Xiang B., Deng H., Xiang S., Lu J. Improved stochastic resonance algorithm for enhancement of signal-to-noise ratio of high-performance liquid chromatographic signal. Anal. Chim. Acta 2007, 585:60-65.
31. Shah R.B., Yang Y., Khan M.A., Faustino P.J. Molecular weight determination for colloidal iron by Taguchi optimized validated gel permeation chromatography. Int. J. Pharm. 2008, 353:21-27.
32. Bianchini R.M., Castellano P.M., Kaufman T.S. Development and validation of an HPLC method for the determination of process-related impurities in pridinol mesylate, employing experimental designs. Anal. Chim. Acta 2009, 654:141-147.